176 related articles for article (PubMed ID: 9498027)
1. Acyclovir cream prevents clinical and thermographic progression of recrudescent herpes labialis beyond the prodromal stage.
Biagioni PA; Lamey PJ
Acta Derm Venereol; 1998 Jan; 78(1):46-7. PubMed ID: 9498027
[TBL] [Abstract][Full Text] [Related]
2. Thermographic resolution of the prodromal phase of herpes labialis treated with acyclovir.
Lamey PJ; Biagioni PA
Dentomaxillofac Radiol; 1995 Aug; 24(3):201-3. PubMed ID: 8617397
[TBL] [Abstract][Full Text] [Related]
3. Electronic infrared thermography as a method of assessing herpes labialis infection.
Biagioni PA; Lamey PJ
Acta Derm Venereol; 1995 Jul; 75(4):264-8. PubMed ID: 8578944
[TBL] [Abstract][Full Text] [Related]
4. Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. Topical Penciclovir Collaborative Study Group.
Spruance SL; Rea TL; Thoming C; Tucker R; Saltzman R; Boon R
JAMA; 1997 May; 277(17):1374-9. PubMed ID: 9134943
[TBL] [Abstract][Full Text] [Related]
5. Double-blind, randomized, placebo-controlled study of topical 5% acyclovir-1% hydrocortisone cream (ME-609) for treatment of UV radiation-induced herpes labialis.
Evans TG; Bernstein DI; Raborn GW; Harmenberg J; Kowalski J; Spruance SL
Antimicrob Agents Chemother; 2002 Jun; 46(6):1870-4. PubMed ID: 12019102
[TBL] [Abstract][Full Text] [Related]
6. Safety and tolerability of combination acyclovir 5% and hydrocortisone 1% cream in adolescents with recurrent herpes simplex labialis.
Strand A; Böttiger D; Gever LN; Wheeler W
Pediatr Dermatol; 2012; 29(1):105-10. PubMed ID: 22004219
[TBL] [Abstract][Full Text] [Related]
7. Penciclovir cream for the treatment of sunlight-induced herpes simplex labialis: a randomized, double-blind, placebo-controlled trial. Penciclovir Cream Herpes Labialis Study Group.
Boon R; Goodman JJ; Martinez J; Marks GL; Gamble M; Welch C
Clin Ther; 2000 Jan; 22(1):76-90. PubMed ID: 10688392
[TBL] [Abstract][Full Text] [Related]
8. Herpes Labialis: An Update.
Leung AKC; Barankin B
Recent Pat Inflamm Allergy Drug Discov; 2017; 11(2):107-113. PubMed ID: 28971780
[TBL] [Abstract][Full Text] [Related]
9. The role of topical 5% acyclovir and 1% hydrocortisone cream (Xerese™) in the treatment of recurrent herpes simplex labialis.
Hull CM; Brunton S
Postgrad Med; 2010 Sep; 122(5):1-6. PubMed ID: 20873400
[TBL] [Abstract][Full Text] [Related]
10. Failure of acyclovir cream in treatment of recurrent herpes labialis.
Shaw M; King M; Best JM; Banatvala JE; Gibson JR; Klaber MR
Br Med J (Clin Res Ed); 1985 Jul; 291(6487):7-9. PubMed ID: 3926067
[TBL] [Abstract][Full Text] [Related]
11. Acyclovir cream for treatment of herpes simplex labialis: results of two randomized, double-blind, vehicle-controlled, multicenter clinical trials.
Spruance SL; Nett R; Marbury T; Wolff R; Johnson J; Spaulding T
Antimicrob Agents Chemother; 2002 Jul; 46(7):2238-43. PubMed ID: 12069980
[TBL] [Abstract][Full Text] [Related]
12. Acyclovir in the management of herpes labialis.
Yeo JM; Fiddian AP
J Antimicrob Chemother; 1983 Sep; 12 Suppl B():95-103. PubMed ID: 6355056
[TBL] [Abstract][Full Text] [Related]
13. Topical iontophoretic administration of acyclovir for the episodic treatment of herpes labialis: a randomized, double-blind, placebo-controlled, clinic-initiated trial.
Morrel EM; Spruance SL; Goldberg DI;
Clin Infect Dis; 2006 Aug; 43(4):460-7. PubMed ID: 16838235
[TBL] [Abstract][Full Text] [Related]
14. Recent approval of Xerese in Canada: 5% acyclovir and 1% hydrocortisone topical cream in the treatment of herpes labialis.
Nguyen HP; Stiegel KR; Downing C; Stiegel KR
Skin Therapy Lett; 2014; 19(3):5-8. PubMed ID: 25188362
[TBL] [Abstract][Full Text] [Related]
15. Protocol for a randomised controlled trial of 90% kanuka honey versus 5% aciclovir for the treatment of herpes simplex labialis in the community setting.
Semprini A; Singer J; Shortt N; Braithwaite I; Beasley R;
BMJ Open; 2017 Aug; 7(8):e017766. PubMed ID: 28775197
[TBL] [Abstract][Full Text] [Related]
16. Successful treatment of herpes labialis with topical acyclovir.
Fiddian AP; Yeo JM; Stubbings R; Dean D
Br Med J (Clin Res Ed); 1983 May; 286(6379):1699-701. PubMed ID: 6405939
[TBL] [Abstract][Full Text] [Related]
17. A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis.
Horwitz E; Pisanty S; Czerninski R; Helser M; Eliav E; Touitou E
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1999 Jun; 87(6):700-5. PubMed ID: 10397661
[TBL] [Abstract][Full Text] [Related]
18. Prophylaxis against herpes labialis with acyclovir cream--a placebo-controlled study.
Gibson JR; Klaber MR; Harvey SG; Tosti A; Jones D; Yeo JM
Dermatologica; 1986; 172(2):104-7. PubMed ID: 3512326
[TBL] [Abstract][Full Text] [Related]
19. Herpes labialis in skiers: randomized clinical trial of acyclovir cream versus placebo.
Raborn GW; Martel AY; Grace MG; McGaw WT
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Dec; 84(6):641-5. PubMed ID: 9431533
[TBL] [Abstract][Full Text] [Related]
20. [Acyclovir for prevention of recurrent Herpes labialis?].
Färber I
Med Monatsschr Pharm; 2008 Jun; 31(6):226. PubMed ID: 18661914
[No Abstract] [Full Text] [Related]
[Next] [New Search]